WPRIM Management System> DCMS> Journal of Rheumatic Diseases> 2022> 29> 2

Volume: 29 Issue: 2

1. A Case of Macrophage Activation Syndrome During the Treatment of Adult-onset Still’s Disease With Tocilizumab Page:123—128
2. Idiopathic Inflammatory Arthritis in the Auditory Canal in a Patient With Hearing Impairment: A Case Report and Literature Review Page:116—122
3. Differential Diagnosis of Inflammatory Arthropathy Accompanying Active Tuberculosis Infection Page:108—115
4. Time-integrated Cumulative Parameters Predictive of Radiographic Progression of Rheumatoid Arthritis: Real-world Data From a Prospective Single-center Cohort Page:98—107
5. Evaluation of Serum Matrix Metalloproteinase-3 as an Objective Indicator for the Disease Activity in Rheumatoid Arthritis Patients Treated With Methotrexate Versus Tocilizumab: 24-week Results From a Prospective Randomized Controlled Study Page:89—97
6. Assessment on Treatments With Conventional Synthetic Disease-modifying Drugs Before Initiating Biologics in Patients With Rheumatoid Arthritis in Korea: A Populationbased Study Page:79—88
7. The Korean College of Rheumatology: 40 Years of Public Health Influence Page:75—78
8. Korean College of Rheumatology: Forty Years of Excellence Page:71—74
9. Recent Advances in Basic and Clinical Aspects of Rheumatoid Arthritis-associated Interstitial Lung Diseases Page:61—70
10. Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis Page:59—60

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.